Amgen warns investors of ‘mini-tender’ offer
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
Biotech giant Amgen warned investors of a so-called “mini-tender” offer by TRC Capital Corp. that seeks to buy half a million of the company’s shares at below-market prices ahead of its third quarter earnings. The unsolicited offer is dated Oct. 11 and offers to purchase up to 500,000 of Amgen common stock at $192 per Read More →
Read More →Dubroff: Zuckerberg plays monopoly, dodges the truth
![Henry Dubroff](https://dev.pacbiztimes.com/wp-content/uploads/2013/11/Henry-WEB-color-cropped-201x224.jpg)
After watching Facebook chief executive Mark Zuckerberg labor to explain his company’s policies on privacy, diversity and currency in testimony before Congress on Oct. 23, I have come to some conclusions about the social media giant and its future. Like any company with monopoly or near-monopoly power, Facebook is way too concerned about costs. It Read More →
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Amgen CFO retiring in 2020
![](https://dev.pacbiztimes.com/wp-content/uploads/2017/01/44-amgen-web-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Amgen declares fourth-quarter dividend
![](https://dev.pacbiztimes.com/wp-content/uploads/2014/01/amgen-flagWEB-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Biotech firm Arcutis gets $94.5M in funding round
![](https://dev.pacbiztimes.com/wp-content/uploads/2019/10/Arcutis-logo-300x184.png)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →![Premium Content](https://dev.pacbiztimes.com/wp-content/themes/e9bqxucyjgdpwjvsw8/images/premium.gif)
Sienna Bio looks to bring laser hair removal product to market
![](https://dev.pacbiztimes.com/wp-content/uploads/2016/05/11-kythera-color-web-300x224.jpg)
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →